These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2573147)

  • 21. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
    Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
    Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rioprostil, a new prostaglandin E1, prevents cyclosporin A-induced damage to endocrine and exocrine pancreas.
    Müller M; Degenhardt H; Bergmann K; Coone H; Löhr M; Klöppel G; Goebell H
    Scand J Gastroenterol Suppl; 1989; 164():35-41. PubMed ID: 2510278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
    Dammann HG; Rehner M; Walter TA; Müller P; Simon B
    Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
    Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
    Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
    Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
    Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoxygenase metabolites in the rat gastric microvascular response to intragastric ethanol.
    Yonei Y; Guth PH
    Gastroenterology; 1989 Aug; 97(2):304-12. PubMed ID: 2501140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rioprostil, a new prostaglandin E1 analogue does not affect glucose homeostasis in healthy volunteers.
    Eichler HG; Korn A; Businger JA; Waldhäusl WK
    Arch Int Pharmacodyn Ther; 1989; 298():288-92. PubMed ID: 2502955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of chronic omeprazole treatment on gastric endocrine function.
    Koop H; Schwarting H; Knorr-Marin A; Willhardt C; Möser T; Arnold R
    Klin Wochenschr; 1987 Feb; 65(4):169-73. PubMed ID: 2882060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
    Demol P; Wingender W; Kuhlmann J
    Scand J Gastroenterol Suppl; 1989; 164():68-71; discussion 71-2. PubMed ID: 2510284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of rioprostil on the gastric acid and bicarbonate secretion in patients with gastric ulcer.
    Krastev Z; Deredjian S; Matincheva R; Spasova Z; Karakasheva V
    Scand J Gastroenterol Suppl; 1989; 164():141-5. PubMed ID: 2510258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of prostaglandins on gastric emptying.
    Penston JG; Wormsley KG
    Scand J Gastroenterol Suppl; 1989; 164():127-32. PubMed ID: 2510256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostaglandin E2 and D2 on gastric somatostatin and gastrin secretion.
    Takemura J; Seino Y; Nishi S; Ishida H; Sakita M; Taminato T; Chiba T; Imura H
    Regul Pept; 1983 Aug; 6(4):379-84. PubMed ID: 6138820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of rioprostil on indomethacin-induced lesions of gastric and duodenal mucosa in healthy volunteers.
    Vlahov V; Kirkov V; Popov P; Gerova Z
    Scand J Gastroenterol Suppl; 1989; 164():169-73. PubMed ID: 2510262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin.
    Katz LB; Shriver DA
    J Pharmacol Exp Ther; 1989 Nov; 251(2):774-81. PubMed ID: 2509683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic evaluation of rioprostil in the management of non-steroidal anti-inflammatory drug-induced gastritis: an interim analysis.
    Caldwell JR; Weaver AL; Brown SK; McCormack GH
    Scand J Gastroenterol Suppl; 1989; 164():239-41. PubMed ID: 2510275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single evening dose of rioprostil, 600 micrograms, in the treatment of acute duodenal ulcers.
    Dammann HG; Dreyer M; Müller P; Simon B; Demol P
    Scand J Gastroenterol Suppl; 1989; 164():215-8. PubMed ID: 2510271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of rioprostil with the parietal cell prostaglandin E2 receptor.
    Beinborn M; Nüstedt V; Sewing KF
    Scand J Gastroenterol Suppl; 1989; 164():21-4; discussion 24-5. PubMed ID: 2554487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of rioprostil on oesophageal motility.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 164():118-9. PubMed ID: 2510254
    [No Abstract]   [Full Text] [Related]  

  • 40. Response of the antral mucosa of the rat stomach to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Theobald HM; Ingall GB; Mably TA; Peterson RE
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):167-79. PubMed ID: 1672476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.